Trial intelligence / Profile preview

NuQu for Degenerative Lumbar Discs

NCT01771471Phase 2Terminated

Sponsor
Isto Biologics
Start
Nov 2012
Primary completion
Sep 2020
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of NuQu in degenerative disc disease (DDD), sponsored by Isto Biologics. Started Nov 2012; status: terminated.

02

Drugs

NuQu
03

Conditions

degenerative disc disease (DDD)

Beyond the preview

Go deeper on NCT01771471.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01771471.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call